Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).

por Natsuda Aumpan, Ratha-Korn Vilaichone, Bubpha Pornthisarn, Soonthorn Chonprasertsuk, Sith Siramolpiwat, Patommatat Bhanthumkomol, Pongjarat Nunanan, Navapan Issariyakulkarn, Sarita Ratana-Amornpin, Muhammad Miftahussurur, Varocha Mahachai, Yoshio Yamaoka
Publicado 2021